MustGrow Successfully Imports TerraMG To Colombia For Laboratory Testing

MustGrow Biologics (CSE: MGRO) announced this morning that it has successfully imported its flagship TerraMG bio-pesticide into Colombia for the purpose of testing the product on the infamous Panama Disease. Panama Disease presents an existential threat to that of the global banana industry.

The disease is a strain of fusarium, and is a devastating disease pathogen that threatens the global banana industry, an industry pegged at $25 billion. Once in the soil, the disease can remain viable for decades and can ultimately result in a 100% yield loss. Panama Disease also has a particular affinity for Cavendish bananas, which accounts for half of all bananas produced. Given the prior success demonstrated by MustGrow’s mustard-derived TerraMG product on achieving 100% control of fusarium, the product is being tested on the strain responsible for large losses in the banana industry.

Laboratory testing being conducted within Colombia will focus on eradicating the disease, with research conducted serving as a benchmark for acquiring registration labels for the TerraMG product in Colombia and other South American countries. TerraMG is currently in the process of acquiring US-EPA and Canadian-PMRA registrations for the product for use as a pre-plant treatment against soil borne pests and diseases.

This is a huge milestone for MustGrow, as we expand our footprint from North America to South America. The Colombian government has declared a National State of Emergency, with no viable options available to combat Panama Disease – we look forward to potentially aiding not only Colombian farmers, but the health and prosperity of the nation itself.

Colin Bletsky, COO of MustGrow Biologics

The move to import TerraMG into Colombia for testing against Panama Disease is a part of MustGrow’s recently announced South American strategy. The company intends to pursue registration for the product for uses that include high value crops in the region such as coffee, oil palm, various floraculture, and of course, bananas. After the completion of successful laboratory testing, the company intends to conduct further field tests to analyze the efficacy of the product against numerous soil-borne diseases and pests in the South American region.

MustGrow Biologics last traded at $0.30 on the CSE.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Tariffs Spark New Race for Critical Metals | Rob McEwen

Antimony Resources: The Bald Hill Project

They Laughed at $3,000 Gold, Now We’re Headed for $4,000! | Sean Roosen – Osisko Development Corp.

Recommended

Steadright Begins Preliminary Economic Assessment On TitanBeach Project

Three Miners Trapped Underground At Newmont’s Red Chris Mine

Related News

MustGrow Posts Positive Field Trials Results – The Daily Dive

To start off this week’s Daily Dive, we see the return of Colin Bletsky, COO...

Monday, November 15, 2021, 01:30:00 PM

MustGrow Biologics Initiates South American Strategy

MustGrow Biologics (CSE: MGRO) has initiated a South American strategy for the registration of TerraMG...

Tuesday, May 5, 2020, 11:13:30 AM

MustGrow Biologics Sees CannaPM Approved For Use Against Powdery Mildew In Cannabis And Hemp

It appears that revenues might be coming in the near term to MustGrow Biologics (CSE:...

Wednesday, February 24, 2021, 07:11:49 AM

MustGrow Study Reveals 96.1% Disease Control Of Clubroot Via Greenhouse Tests With TerraMG

MustGrow Biologics (CSE: MGRO) this morning released results from its successful greenhouse soil test results...

Wednesday, August 26, 2020, 09:28:03 AM

MustGrow Enters Exclusive Marketing And Distribution Agreement With NexusBioAg

MustGrow Biologics (CSE: MGRO) has seen further validation of its tech this morning, with the...

Wednesday, July 20, 2022, 08:23:29 AM